Adeoye Y. Olukotun, Director: Arrowhead Pharmaceuticals ARWR Planned sale · Filed 25/12/19

Trade details

Type: Planned sale notice
Stock: Arrowhead Pharmaceuticals ARWR
Person: Adeoye Y. OlukotunDirector
Planned sale date: 25/12/19
Filed: 25/12/19

$676.6K to be sold

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/19~01/18

Adeoye Y. Olukotun's recent trades

Adeoye Y. OlukotunDirector
Planned saleArrowhead Pharmaceuticals
Planned sale
Arrowhead Pharmaceuticals
ARWR
$173.9K
2,000 sh
$173.9K
Filed 08/18
Traded 08/18
Adeoye Y. OlukotunDirector
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$413.9K
6,083 sh
$413.9K
Filed 25/12/23
Traded 25/12/19
Adeoye Y. OlukotunDirector
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$206.1K
3,090 sh
$206.1K
Filed 25/12/23
Traded 25/12/19
Adeoye Y. OlukotunDirector
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$56.6K
827 sh
$56.6K
Filed 25/12/23
Traded 25/12/19
Adeoye Y. OlukotunDirector
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$20.1K
959 sh
$20.1K
Filed 25/01/27
Traded 25/01/23